|
WO2021080301A1
|
|
RNA APTAMER SPECIFICALLY BINDING TO LXRα PROTEIN AND USE OF RNA APTAMER
|
|
WO2021060926A1
|
|
Chimeric cytokine receptor capable of immune signal conversion, immune cells expressing same, and anti-cancer use thereof
|
|
WO2021066420A1
|
|
Chimeric antigen receptor specifically binding to cd138, immune cell expressing same, and anticancer use thereof
|
|
KR20200110638A
|
|
Composition for prevention or treatment of atopic dermatitis and skin trouble care comprising Astaxanthin Liposome as effective component
|
|
KR20200110287A
|
|
Composition for prevention or treatment of atopic dermatitis and skin trouble care comprising Astaxanthin Liposome as effective component
|
|
KR20200103593A
|
|
primer set and detection method for influenza virus subtype
|
|
US2021093693A1
|
|
Novel use of git having anti-senescence activity
|
|
KR20200135187A
|
|
Composition comprising extract of Abeliophyllum distichum for prevention or treatment of bone diseases
|
|
KR102185207B1
|
|
Disinfecting pen for button touch
|
|
KR102188594B1
|
|
Electric mask with head mounted elastic band
|
|
KR102188598B1
|
|
Functional mask having air shield function
|
|
KR20200044760A
|
|
Vacuum cleaner having an dust scattering preventing function
|
|
KR20200045998A
|
|
A method for producing an oral crumbling film comprising meloxicam and a oral crumbling film produced thereby
|
|
KR102224472B1
|
|
Molecular marker for predicting fruit shape of pear and use thereof
|
|
KR20200024190A
|
|
Pharmaceutical composition comprising miconazole for prevention or treatment of degenerative diseases of central nervous system
|
|
KR102192442B1
|
|
Balanced leader distribution method and system in kubernetes cluster
|
|
KR20200097661A
|
|
Method for cultivating or increasing of saponin contents of sprout ginseng using led
|
|
KR102212406B1
|
|
Scheduling method and scheduling system in ad hoc networks
|
|
KR102151225B1
|
|
Molecular marker based on nuclear genome sequence for discriminating Platycodon grandiflorum landraces and uses thereof
|
|
WO2020138974A1
|
|
Pharmaceutical composition containing magnolia obovata extract as active ingredient for prevention or treatment of anxiety disorder
|
